ICU Medical develops and manufactures infusion therapy and critical-care products used in hospitals and clinical settings. Its portfolio spans IV pumps and sets, needle-free connectors, closed system transfer devices for hazardous drugs, pharmacy preparation tools, and hemodynamic monitoring. The company is known for systems designed to reduce bloodstream infection risk and protect clinicians from exposure to infectious material and toxic medications. Customers are primarily acute-care providers standardizing safe IV and pharmacy workflows.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 604.7 | — | -15.5 | — |
| Q2 2025 | 548.9 | — | 35.3 | — |
| Q3 2025 | 537 | — | -3.4 | — |
| Q4 2025 | 540.7 | — | -15.7 | — |
| Q1 2026 | 530.2 | -12.3% | 30.1 | — |
| Q2 2026 | 551.7 | 0.5% | 19.1 | -46% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: JOYY Inc. (JOYY), Edgewise Therapeutics, Inc. (EWTX), Enphase Energy, Inc. (ENPH), CorVel Corporation (CRVL), Cavco Industries, Inc. (CVCO), Cathay General Bancorp (CATY)